Efficacy of Ifosfamide-Cisplatin-Etoposide (ICE) Chemotherapy for a CNS Germinoma in a Child With Down Syndrome
Journal of Pediatric Hematology/Oncology2016Vol. 39(1), pp. e39–e42
Citations Over TimeTop 25% of 2016 papers
Seishiro Nodomi, Katsutsugu Umeda, Hiroo Ueno, Satoshi Saida, Hidefumi Hiramatsu, Takeshi Funaki, Yoshiki Arakawa, Takashi Mizowaki, Souichi Adachi, Toshio Heike
Abstract
Intracranial germ cell tumor is sometimes associated with Down syndrome; however, no optimal treatment has been developed due to the high risk of recurrence and treatment-related mortality. Here, we report on a patient with an intracranial germinoma in the bilateral basal ganglia. The patient received 3 courses of ifosfamide-cisplatin-etoposide in combination with whole-brain irradiation (24 Gy), with no serious complications. The patient is alive and disease free 16 months after the initial diagnosis. This regimen is a feasible treatment for intracranial germ cell tumor associated with Down syndrome, although careful attention must be paid to the increased risk for severe infection.
Related Papers
- → Anticancer activity of the combination of cisplatin and etoposide in endometrial cancer-bearing nude mice(1991)3 cited
- → Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood: A pediatric oncology group study(1993)6 cited
- → A Phase I/II Study of a 72‐h Continuous Infusion of Etoposide in Advanced Soft Tissue Sarcoma(1997)5 cited
- → Ifosfamide and Etoposide Salvage Treatment in Advanced Ovarian Cancer(1991)5 cited
- → Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors(1982)28 cited